# a16z Capital Management, L.L.C.: Form 13F holdings

An institutional investment manager in MENLO PARK, CA. SEC CIK 1540358.

- Quarter ended: 2026-06-30
- Filed: 2026-08-14
- Reported value: $14.21bn
- Positions: 19 (19 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1540358/000154035826000010/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [SPACE EXPLORATION TECHN CORP (SPCX)](/companies/spcx.md) | CLASS A COM STK | $12.79bn | 90.0% | 74,855,020 |  | New +74,855,020 |
| [NAVAN INC (NAVN)](/companies/navn.md) | CL A | $645.4m | 4.5% | 28,218,676 |  | Unchanged |
| [REVOLUTION MEDICINES INC (RVMD)](/companies/rvmd.md) | COM | $172.5m | 1.2% | 921,099 |  | Unchanged |
| [META PLATFORMS INC (META)](/companies/meta.md) | CL A | $119.7m | 0.8% | 212,531 |  | Unchanged |
| [FIGMA INC (FIG)](/companies/fig.md) | CLASS A COM STK | $108.2m | 0.8% | 5,983,308 |  | Reduced −10,028,070 |
| [BIOAGE LABS INC (BIOA)](/companies/bioa.md) | COM | $79.2m | 0.6% | 3,233,170 |  | Unchanged |
| [BLOCK INC (XYZ)](/companies/xyz.md) | CL A | $77.3m | 0.5% | 1,016,697 |  | Unchanged |
| [ERASCA INC (ERAS)](/companies/eras.md) | COM | $52.4m | 0.4% | 2,862,500 |  | Unchanged |
| [MAZE THERAPEUTICS INC (MAZE)](/companies/maze.md) | COM | $50.8m | 0.4% | 1,702,225 |  | Unchanged |
| DAMORA THERAPEUTICS INC | COM NEW | $32.2m | 0.2% | 1,236,157 |  | Unchanged |
| [OMADA HEALTH INC (OMDA)](/companies/omda.md) | COM | $25.3m | 0.2% | 1,153,639 |  | Reduced −1,153,645 |
| [NAUTILUS BIOTECHNOLOGY INC (NAUT)](/companies/naut.md) | COM | $16.9m | 0.1% | 9,063,054 |  | Reduced −8,590,863 |
| [ROBLOX CORP (RBLX)](/companies/rblx.md) | CL A | $14.9m | 0.1% | 274,570 |  | New +274,570 |
| [AKTIS ONCOLOGY INC (AKTS)](/companies/akts.md) | COM | $13.4m | <0.1% | 415,000 |  | Unchanged |
| [CAMP4 THERAPEUTICS CORP (CAMP)](/companies/camp.md) | COM | $9.3m | <0.1% | 2,125,339 |  | Unchanged |
| [BITGO HOLDINGS INC (BTGO)](/companies/btgo.md) | COM SHS CL A | $3.5m | <0.1% | 666,356 |  | Unchanged |
| [KAILERA THERAPEUTICS INC (KLRA)](/companies/klra.md) | COMMON STOCK | $3.1m | <0.1% | 140,000 |  | New +140,000 |
| [GINKGO BIOWORKS HOLDINGS INC (DNA)](/companies/dna.md) | CL A NEW | $1.1m | <0.1% | 108,568 |  | Unchanged |
| [IP STRATEGY HOLDINGS INC (IPST)](/companies/ipst.md) | COM | $9.7k | <0.1% | 4,137 |  | New +4,137 |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| IP STRATEGY HOLDINGS INC | COM | $0 | 0.0% | 0 |  | Sold out −82,740 |

Source: SEC EDGAR, Form 13F-HR, accession 0001540358-26-000010. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.